ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,079,635 | +1.8% | 114,313 | +16.0% | 0.01% | -16.7% |
| Q2 2023 | $3,025,302 | -20.8% | 98,511 | -7.4% | 0.01% | -33.3% |
| Q1 2023 | $3,819,820 | +156.7% | 106,411 | +182.7% | 0.01% | +125.0% |
| Q4 2022 | $1,487,766 | -61.9% | 37,646 | -61.2% | 0.00% | -81.0% |
| Q3 2022 | $3,902,000 | +266.4% | 97,079 | +289.3% | 0.02% | +320.0% |
| Q2 2022 | $1,065,000 | -31.3% | 24,935 | -29.1% | 0.01% | 0.0% |
| Q1 2022 | $1,550,000 | +75.1% | 35,184 | +55.7% | 0.01% | +66.7% |
| Q4 2021 | $885,000 | – | 22,595 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |